Autophagy Induction by Endothelial-Monocyte Activating Polypeptide II Contributes to the Inhibition of Malignant Biological Behaviors by the Combination of EMAP II with Rapamycin in Human Glioblastoma

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2015 Dec 10

PMID 26648842

Citations 13

Authors

Jun Ma

Fanjie Meng

Shuai Li

Libo Liu

Lini Zhao

Yunhui Liu

Yi Hu

Zhen Li

Yilong Yao

Zhuo Xi

Hao Teng

Yixue Xue

Affiliations

Soon will be listed here.

Abstract

This study aims to investigate the effect of endothelial-monocyte activating polypeptide II (EMAP II) on human glioblastoma (GBM) cells and glioblastoma stem cells (GSCs) as well as its possible mechanisms. In this study, EMAP II inhibited the cell viability and decreased the mitochondrial membrane potential in human GBM cells and GSCs, and autophagy inhibitor 3-methyl adenine (3-MA) blocked these effects. Autophagic vacuoles were formed in these cells after EMAP II treatment and this phenomenon was blocked by 3-MA. In addition, the up-regulation of microtubule-associated protein-1 light chain-3 (LC3)-II and the down-regulation of autophagic degraded substrate p62/SQSTM1 caused by EMAP II were observed. Cells treated with EMAP-II inhibited the PI3K/Akt/mTOR signal pathway, and PI3K/Akt agonist insulin-like growth factor-1 (IGF-1) blocked the effect of EMAP II on the expression of LC3-II and p62/SQSTM1. Cells exposed to EMAP-II experienced mitophagy and ER stress. Furthermore, the inhibition of cell proliferation, migration and invasion of GBM cells and GSCs were more remarkable by the combination of EMAP II and rapamycin than either agent alone in vitro and in vivo. The current study demonstrated that the cytotoxicity of EMAP II in human GBM cells and GSCs was induced by autophagy, accompanied by the inhibition of PI3K/Akt/mTOR signal pathway, mitophagy and ER stress. The combination of EMAP II with rapamycin demonstrated the inhibitory effect on the malignant biological behaviors of human GBM cells and GSCs in vitro and in vivo.

Citing Articles

Astaxanthin Inhibits HO-Induced Excessive Mitophagy and Apoptosis in SH-SY5Y Cells by Regulation of Akt/mTOR Activation.

Yan T, Ding F, Zhang Y, Wang Y, Wang Y, Zhang Y Mar Drugs. 2024; 22(2).

PMID: 38393028 PMC: 10890442. DOI: 10.3390/md22020057.

Changes in the expression of endothelial monocyte‑activating polypeptide II in the rat hippocampus following status epilepticus.

Li C, Ma W, Zhao Y, Wang H Int J Mol Med. 2021; 47(2):699-707.

PMID: 33416103 PMC: 7797450. DOI: 10.3892/ijmm.2020.4808.

Quantitative Ultrastructural Morphometry and Gene Expression of mTOR-Related Mitochondriogenesis within Glioblastoma Cells.

Ferese R, Lenzi P, Fulceri F, Biagioni F, Fabrizi C, Gambardella S Int J Mol Sci. 2020; 21(13).

PMID: 32604996 PMC: 7370179. DOI: 10.3390/ijms21134570.

Inhibition of mTOR Alleviates Early Brain Injury After Subarachnoid Hemorrhage Via Relieving Excessive Mitochondrial Fission.

Li Y, Wu P, Dai J, Zhang T, Bihl J, Wang C Cell Mol Neurobiol. 2019; 40(4):629-642.

PMID: 31728694 PMC: 11448794. DOI: 10.1007/s10571-019-00760-x.

Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p.

Zhang J, Liu L, Xue Y, Ma Y, Liu X, Li Z Front Mol Neurosci. 2018; 11:92.

PMID: 29632473 PMC: 5879952. DOI: 10.3389/fnmol.2018.00092.

References

Murray J, Symonds P, Ward W, Huggins M, Tiga A, Rice K . Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism. J Immunol. 2003; 172(1):274-81. DOI: 10.4049/jimmunol.172.1.274. View

Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol. 2008; 88(1):97-103. DOI: 10.1007/s11060-008-9538-0. View

Cook K, Clarke P, Parmar J, Hu R, Schwartz-Roberts J, Abu-Asab M . Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death. FASEB J. 2014; 28(9):3891-905. PMC: 4139896. DOI: 10.1096/fj.13-247353. View

Kanzawa T, Germano I, Komata T, Ito H, Kondo Y, Kondo S . Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004; 11(4):448-57. DOI: 10.1038/sj.cdd.4401359. View

Yao Y, Ma J, Xue Y, Wang P, Li Z, Li Z . MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Mol Oncol. 2014; 9(3):640-56. PMC: 5528701. DOI: 10.1016/j.molonc.2014.11.003. View

Shin S, Lee K, Choi Y, Lim H, Lee H, Lim Y . The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis. 2013; 34(9):2080-9. DOI: 10.1093/carcin/bgt169. View

Kim I, Rodriguez-Enriquez S, Lemasters J . Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys. 2007; 462(2):245-53. PMC: 2756107. DOI: 10.1016/j.abb.2007.03.034. View

Piccirillo S, Binda E, Fiocco R, Vescovi A, Shah K . Brain cancer stem cells. J Mol Med (Berl). 2009; 87(11):1087-95. DOI: 10.1007/s00109-009-0535-3. View

Nakamura O, Hitora T, Yamagami Y, Mori M, Nishimura H, Horie R . The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells. Int J Mol Med. 2014; 33(6):1491-7. PMC: 4055350. DOI: 10.3892/ijmm.2014.1715. View

10.

Nabissi M, Morelli M, Amantini C, Liberati S, Santoni M, Ricci-Vitiani L . Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner. Int J Cancer. 2015; 137(8):1855-69. DOI: 10.1002/ijc.29573. View

11.

Fu J, Shao C, Chen F, Ng H, Chen Z . Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro Oncol. 2010; 12(4):328-40. PMC: 2940599. DOI: 10.1093/neuonc/nop005. View

12.

Schroder M . Endoplasmic reticulum stress responses. Cell Mol Life Sci. 2007; 65(6):862-94. PMC: 11131897. DOI: 10.1007/s00018-007-7383-5. View

13.

Berger A, Alexander H, Tang G, Wu P, Hewitt S, Turner E . Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res. 2000; 60(1):70-80. DOI: 10.1006/mvre.2000.2249. View

14.

Xu H, Huang Y, Xie Z, Lin L, Guo Y, Zhuang Z . The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients. BMC Cancer. 2013; 13:247. PMC: 3663650. DOI: 10.1186/1471-2407-13-247. View

15.

Hadjipanayis C, Van Meir E . Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol Med. 2009; 15(11):519-30. PMC: 2782740. DOI: 10.1016/j.molmed.2009.09.003. View

16.

Fasolo A, Sessa C . Targeting mTOR pathways in human malignancies. Curr Pharm Des. 2012; 18(19):2766-77. DOI: 10.2174/138161212800626210. View

17.

Cherla R, Lee S, Mulder R, Lee M, Tesh V . Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Infect Immun. 2009; 77(9):3919-31. PMC: 2737994. DOI: 10.1128/IAI.00738-09. View

18.

Faisal W, Symonds P, Panjwani S, Heng Y, Murray J . Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes. Asian J Surg. 2007; 30(1):13-22. DOI: 10.1016/S1015-9584(09)60122-6. View

19.

Strappazzon F, Vietri-Rudan M, Campello S, Nazio F, Florenzano F, Fimia G . Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. EMBO J. 2011; 30(7):1195-208. PMC: 3094111. DOI: 10.1038/emboj.2011.49. View

20.

Scaringi C, Maurizi Enrici R, Minniti G . Combining molecular targeted agents with radiation therapy for malignant gliomas. Onco Targets Ther. 2013; 6:1079-95. PMC: 3745290. DOI: 10.2147/OTT.S48224. View